EMD Millipore, begun in 1954 as a small filtration company, is poised to become a much larger player in the fast-growing business of supplying life sciences research and production equipment to ...

Singulex Inc., whose technology is used to detect molecular markers of disease, said it is selling its life sciences research business and is concentrating on its diagnostics operations. EMD ...

Merck KGaA life sciences division EMD Millipore announced Tuesday it has agreed to acquire Amnis Corp., a Seattle-based company that makes high-speed cell imaging instruments used in academic ...

EMD Millipore has acquired a global, non-exclusive license for a number of patents relating to induced pluripotent stem (iPS) cells from iPS Academia Japan Inc. (AJ), an affiliate of Kyoto ...

With 10,000 employees in 64 countries, EMD Millipore will be headquartered in Billerica, MA, Millipore’s base. It will be supported by locations throughout the Americas, Europe, and Asia-Pacific.

About EMD Millipore. EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that ...

EMD Millipore and PharmaCell B.V. have announced a collaboration to develop optimized large-scale expansion and harvest of HepaRG® cells using bioreactor technology. The companies will work together ...

EMD Millipore serves as a strategic partner for scientists, engineers, and researchers around the world and has a portfolio of more than 60,000 products.

EMD Millipore's Direct Detect® system was recognized as one of R&D Magazine’s 100 most innovative and technologically significant products to be introduced into the marketplace in the year 2012 ...

EMD Millipore is committed to partnering with its global customers to create innovative solutions for research, development and production that meet the evolving, complex needs ...

Plasticell has licensed EMD Millipore to distribute a superior, single-application osteogenic medium discovered using the award winning, massively parallel combinatorial screening system, CombiCult®.

Firms believe work will lead to a prognostic tool that includes 13 blood markers. EMD Millipore and Proteomics International are joining forces to validate biomarkers related to diabetic nephropathy.